Daniel M Paulson
Affiliation: Sanofi-Aventis Deutschland GmbH
- Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trialDaniel M Paulson
VA Medical Center, Richmond, USA
J Pain 6:184-92. 2005..Alvimopan, a novel peripheral opioid mu-receptor antagonist, has demonstrated significant efficacy for the management of opioid-induced bowel dysfunction without compromise of centrally mediated opioid-induced analgesia...